The Nuances of Diagnosis and Management of Eczema in Skin of Color (Recording)

This Webinar was recorded on May 26th, 2026

Eczema and other immune-mediated skin diseases often present with distinct clinical features in patients with skin of color, contributing to diagnostic challenges, delayed treatment, and disparities in outcomes. Variations in morphology, pigmentation, and distribution can complicate disease recognition and severity assessment in clinical practice.

Join Dr. Ama Alexis as she reviews the immunopathophysiology and clinical presentation of inflammatory skin diseases in diverse populations. This session will highlight evidence-based strategies to improve diagnostic accuracy, optimize management, and address health inequities impacting patient care.

Target Audience
This activity is intended for dermatologists, allergists/immunologists, primary care clinicians, nurse practitioners, physician assistants, and other healthcare professionals involved in the diagnosis and management of inflammatory skin diseases.

Speaker:

Dr. Ama Alexis

Dr. Ama Alexis is a Clinical Assistant Professor of Pediatrics affiliated with NYU Langone Medical Center and Weill Cornell Medical College. She is double boarded in Allergy/Immunology and Pediatrics. She is a Fellow of the American Academy of Allergy, Asthma, and Immunology, the American College of Allergy, Asthma, and Immunology, and the American Academy of Pediatrics. Dr. Alexis is passionate about educating and empowering individuals and families affected by atopic dermatitis and food allergies, advocating regionally and internationally.

This Advances webinar is in partnership with the American College of Allergy, Asthma & Immunology. ACAAI offers CMEs for physicians for this webinar. If you are an ACAAI member, you can obtain CME through the member portal for the Advances webinars.

All attendees will be offered a certificate of attendance. No other continuing education credit is provided.

CME is available through ACAAI for this webinar.

Sponsored by the American College of Allergy, Asthma and Immunology

The Nuances of Diagnosis and Management of Eczema in Skin of Color

Webinar Highlights

In this CME webinar, “The Nuances of Diagnosis and Management of Eczema in Skin of Color,” Dr. Ama Alexis explored the unique challenges associated with diagnosing and treating atopic dermatitis (AD) in patients with skin of color. The session highlighted how eczema can present differently across diverse skin tones, often leading to delayed diagnosis, underestimation of disease severity, and disparities in treatment access and outcomes. Through clinical case studies, evidence-based guidelines, and emerging research, attendees gained insight into the importance of recognizing varied morphologies such as lichenification, perifollicular accentuation, xerosis, and dyspigmentation in darker skin types.

Dr. Alexis also addressed the impact of health disparities in atopic dermatitis care, including higher disease burden, increased emergency department utilization, and differences in prescribing patterns among Black and Hispanic patients. Attendees reviewed practical strategies to improve clinical assessment, including palpation, side-lighting, and comparison of lesional versus non-lesional skin to better identify active inflammation in pigmented skin. In addition, the webinar provided an overview of current and emerging therapies for AD, including topical therapies, biologics, and oral JAK inhibitors, while emphasizing the importance of shared decision-making and culturally informed care approaches.

Key Learning Highlights

• Reviewed clinical and morphological features of atopic dermatitis in skin of color, including erythema, lichenification, perifollicular accentuation, dyspigmentation, and xerosis.
• Examined disparities in diagnosis, disease burden, and treatment access among diverse patient populations with eczema.
• Discussed practical approaches to improving diagnostic accuracy through palpation, lesion comparison, itch assessment, and recognition of subtle inflammatory changes in pigmented skin.
• Explored culturally informed skincare practices and their impact on skin barrier health and disease management.
• Reviewed evidence-based and emerging therapies for atopic dermatitis, including topical therapies, biologics, and JAK inhibitors.
• Highlighted the importance of shared decision-making to support individualized treatment plans and improve quality of life for patients with moderate-to-severe disease.

Target Audience

This activity is intended for dermatologists, allergists/immunologists, primary care clinicians, nurse practitioners, physician assistants, and other healthcare professionals involved in the diagnosis and management of inflammatory skin diseases.